Use of allograft bone matrix in clinical orthopedics.
DBM
allograft
decellularized and demineralized bone matrices
extracellular matrix
tissue repair
Journal
Regenerative medicine
ISSN: 1746-076X
Titre abrégé: Regen Med
Pays: England
ID NLM: 101278116
Informations de publication
Date de publication:
19 Jul 2024
19 Jul 2024
Historique:
medline:
19
7
2024
pubmed:
19
7
2024
entrez:
19
7
2024
Statut:
aheadofprint
Résumé
Clinical orthopedics continuously aims to improve methods for bone formation. Clinical applications where bone formation is necessary include critical long bone defects in orthopedic trauma or tumor patients. Though some biomaterials combined with autologous stem cells significantly improve bone repair, critical-size damages are still challenged with the suitable implantation of biomaterials and donor cell survival. Extracellular matrix (ECM) is the fundamental structure in tissues that can nest and nourish resident cells as well as support specific functions of the tissue type. ECM also plays a role in cell signaling to promote bone growth, healing and turnover. In the last decade, the use of bone-derived ECMs or ECM-similar biomaterials have been widely investigated, including decellularized and demineralized bone ECM. In this article, we reviewed the current productions and applications of decellularized and demineralized bone matrices. We also introduce the current study of whole limb decellularization and recellularization. [Box: see text].
Autres résumés
Type: plain-language-summary
(eng)
[Box: see text].
Identifiants
pubmed: 39028538
doi: 10.1080/17460751.2024.2353473
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM